CA2604420C - Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique - Google Patents

Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique Download PDF

Info

Publication number
CA2604420C
CA2604420C CA002604420A CA2604420A CA2604420C CA 2604420 C CA2604420 C CA 2604420C CA 002604420 A CA002604420 A CA 002604420A CA 2604420 A CA2604420 A CA 2604420A CA 2604420 C CA2604420 C CA 2604420C
Authority
CA
Canada
Prior art keywords
prorenin
downs syndrome
amount
sample
renin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002604420A
Other languages
English (en)
Other versions
CA2604420A1 (fr
Inventor
Murugan R. Pandian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Diagnostics Investments LLC
Original Assignee
Quest Diagnostics Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/229,136 external-priority patent/US6127186A/en
Application filed by Quest Diagnostics Investments LLC filed Critical Quest Diagnostics Investments LLC
Publication of CA2604420A1 publication Critical patent/CA2604420A1/fr
Application granted granted Critical
Publication of CA2604420C publication Critical patent/CA2604420C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
CA002604420A 1999-01-12 2000-01-10 Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique Expired - Fee Related CA2604420C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/229,136 US6127186A (en) 1999-01-12 1999-01-12 Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
US09/229,136 1999-01-12
CA002358504A CA2358504C (fr) 1999-01-12 2000-01-10 Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002358504A Division CA2358504C (fr) 1999-01-12 2000-01-10 Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique

Publications (2)

Publication Number Publication Date
CA2604420A1 CA2604420A1 (fr) 2000-07-20
CA2604420C true CA2604420C (fr) 2009-10-06

Family

ID=38830307

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002604420A Expired - Fee Related CA2604420C (fr) 1999-01-12 2000-01-10 Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique

Country Status (1)

Country Link
CA (1) CA2604420C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021022254A3 (fr) * 2019-08-01 2021-05-27 Mark Evans Procédés et appareil permettant de réduire le risque, et d'identifier l'existence, d'une lésion neurologique à un fœtus humain pendant et avant le travail

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021022254A3 (fr) * 2019-08-01 2021-05-27 Mark Evans Procédés et appareil permettant de réduire le risque, et d'identifier l'existence, d'une lésion neurologique à un fœtus humain pendant et avant le travail

Also Published As

Publication number Publication date
CA2604420A1 (fr) 2000-07-20

Similar Documents

Publication Publication Date Title
EP0663071B1 (fr) Procede de prediction du travail precoce
Bashore et al. Plasma unconjugated estriol values in high-risk pregnancy
Tallon et al. Direct solid-phase enzyme immunoassay of progesterone in saliva.
US5198366A (en) Method for the detection of pregnancy disorders
HUSSA et al. Discordant human chorionic gonadotropin results: causes and solutions
US5605843A (en) Kit for prenatal screening for Down's syndrome
CA2358504C (fr) Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique
Shaarawy et al. The clinical value of microtransferrinuria and microalbuminuria in the prediction of pre-eclampsia
JP3626251B2 (ja) 妊娠異常について妊娠期間中にスクリーニングするための方法および装置
Qiu et al. Enzyme immunoassay method for total urinary follicle-stimulating hormone (FSH) beta subunit and its application for measurement of total urinary FSH
US6025149A (en) Urinary screening for down syndrome and other aneuploidies
US5716853A (en) Prenatal down syndrome screening with assays specific for UGP
CA2604420C (fr) Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique
Weerasekera et al. Monitoring ovarian function by a solid-phase chemiluminescence immunoassay
Cartwright et al. Performance of a new enzyme-linked immunoassay urine pregnancy test for the detection of ectopic gestation
Olshaker Introduction to the new section “Clinical Laboratory in Emergency Medicine” Emergency department pregnancy testing
MacDonald et al. Enzyme-linked immunoassay for placental lactogen in human serum.
EP0283606B1 (fr) Procédé pour la détection des troubles de grossesse
Tulchinsky Hormonal changes in pregnancy as indicators of fetoplacental function
WO1993024838A1 (fr) Methode de depistage permettant de depister chez les femmes le risque d'accouchement avant terme
AU652150B2 (en) Total gonadotropal alpha peptide chain assay
Fletcher Jr Update on pregnancy testing
Feldkamp et al. The measurement of human chorionic gonadotropin for pregnancy testing
Frederick et al. Random urinary pregnanediol glucuronide measurements in pregnancy: lack of utility for evaluation of first-trimester vaginal bleeding
JP2898634B2 (ja) 妊娠障害の測定方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160111